Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Ocean Biomedical, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q3 2024
- Shares held
- 3.68M
- +96.6K (+2.7%) vs. Q3 2024
- Total value
- $2.01M
- −$1.46M (−42.1%) vs. Q3 2024
- New holders
- 4
- 7 more added
- Sold out
- 3
- 4 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCEA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 7 | $5.69K |
| Q1 2025 | 25 | $247.3K |
| Q4 2024 | 22 | $2.01M |
| Q3 2024 | 21 | $3.46M |
| Q2 2024 | 36 | $4.77M |
| Q1 2024 | 46 | $17.1M |
| Q4 2023 | 35 | $3.02M |
| Q3 2023 | 39 | $24.2M |
| Q2 2023 | 35 | $40.6M |
| Q1 2023 | 17 | $47.6M |
| Q4 2022 | 43 | $108.1M |
| Q3 2022 | 40 | $105.9M |
| Q2 2022 | 35 | $102.9M |
| Q1 2022 | 34 | $99.4M |
| Q4 2021 | 26 | $81.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Ocean Biomedical, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FNY Investment Advisers, LLC | 600 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,555 | $0 | 0.00% | +1,555 | New |
| SBI Securities Co., Ltd. | 17 | $9 | 0.00% | +17 | New |
| Bank of America Corp | 87 | $48 | 0.00% | −142−62.0% | Reduced |
| BNP Paribas Arbitrage, SA | 143 | $79 | 0.00% | +143 | New |
| Farther Finance Advisors, LLC | 183 | $101 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 236 | $131 | 0.00% | +27+12.9% | Added |
| FMR LLC | 792 | $438 | 0.00% | −1,647−67.5% | Reduced |
| Citigroup Inc | 4,800 | $2.65K | 0.00% | +4,009+506.8% | Added |
| Tower Research Capital LLC (TRC) | 5,511 | $3.05K | 0.00% | +928+20.2% | Added |
| ACT Advisors, LLC. | 15,911 | $8.80K | 0.00% | −790−4.7% | Reduced |
| Bank of Montreal | 20,000 | $11.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 20,450 | $11.3K | 0.00% | +20,450 | New |
| Northern Trust Corp | 26,775 | $14.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 32,800 | $18.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 39,195 | $21.7K | 0.00% | +6,287+19.1% | Added |
| UBS Group AG | 55,147 | $30.5K | 0.00% | +54,995+36,180.9% | Added |
| BlackRock, Inc. | 60,877 | $33.7K | 0.00% | +126+0.2% | Added |
| Millennium Management LLC | 124,895 | $69.1K | 0.00% | −2,667−2.1% | Reduced |
| Geode Capital Management, LLC | 175,308 | $97.0K | 0.00% | +34,317+24.3% | Added |
| Vanguard Group Inc | 406,529 | $224.8K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 2,688,193 | $1.46M | 0.02% | 00.0% | Unchanged |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,562−100.0% | Sold out |
| Nordwand Advisors, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −399−100.0% | Sold out |